Cardiomyocyte GTP cyclohydrolase 1 protects the heart against diabetic cardiomyopathy

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Wu, Hsiang En ^a,b   Baumgardt, Shelley L ^a   Fang, Juan ^a   Paterson, Mark ^a   Liu, Yanan ^c   Du, Jianhai ^d   Shi, Yang ^e   Qiao, Shigang ^a   Bosnjak, Zeljko J ^a   Warltier, David C ^a   Kersten, Judy R ^a   Ge, Zhi Dong ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c Columbia University ^*  (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e Aurora Health Care   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4-DIAMINOHYPOXANTHINE; BENZYLOXYCARBONYLLEUCYL-LEUCYL-LEUCINE ALDEHYDE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GCH1 PROTEIN, MOUSE; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; HYPOXANTHINE DERIVATIVE; LEUPEPTIN; MITOGEN ACTIVATED PROTEIN KINASE P38; NEURONAL NITRIC OXIDE SYNTHASE; STREPTOZOCIN;

ANIMAL; BLOOD PRESSURE; C57BL MOUSE; CALCIUM SIGNALING; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; CHEMICALLY INDUCED; CHEMISTRY; COMPLICATION; DIABETIC CARDIOMYOPATHY; DISEASE MODEL; DRUG EFFECT; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; GENETICS; HEART VENTRICLE REMODELING; HEMODYNAMICS; METABOLISM; MOUSE; PATHOLOGY; TRANSGENIC MOUSE;

ANIMALS; BLOOD PRESSURE; CALCIUM SIGNALING; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC CARDIOMYOPATHIES; DISEASE MODELS, ANIMAL; GTP CYCLOHYDROLASE; HEMODYNAMICS; HYPOXANTHINES; LEUPEPTINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYOCARDIUM; MYOCYTES, CARDIAC; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE III; P38 MITOGEN-ACTIVATED PROTEIN KINASES; STREPTOZOCIN; VENTRICULAR REMODELING;

EID: 84974802688     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep27925     Document Type: Article

References (72)

1. Maahs, D. M., West, N. A., Lawrence, J. M., & Mayer-Davis, E. J. Epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am 39, 481-497 (2010
2. Shishehbor, M. H., et al. Relation of hemoglobin A1c to left ventricular relaxation in patients with type 1 diabetes mellitus and without overt heart disease. Am J Cardiol 91, 1514-1517 (2003
3. Piya, M. K., et al. Abnormal left ventricular torsion and cardiac autonomic dysfunction in subjects with type 1 diabetes mellitus. Metabolism 60, 1115-1121 (2011
4. Yazici, D., Yavuz, D. G., Toprak, A., Deyneli, O., & Akalin, S. Impaired diastolic function and elevated Nt-proBNP levels in type 1 diabetic patients without overt cardiovascular disease. Acta Diabetol 50, 155-161 (2013
5. Gregg, E. W., et al. Changes in diabetes-related complications in The United States, 1990-2010. N Engl J Med 370, 1514-1523 (2014
6. Miki, T., Yuda, S., Kouzu, H., & Miura, T. Diabetic cardiomyopathy: pathophysiology and clinical features. Heart Fail Rev 18, 149-166 (2013
7. Dandamudi, S., Slusser, J., Mahoney, D. W., Redfield, M. M., Rodeheffer, R. J., & Chen, H. H. The prevalence of diabetic cardiomyopathy: a population-based study in Olmsted County, Minnesota. J Card Fail 20, 304-309 (2014
8. Gregg, E. W., Gu, Q., Cheng, Y. J., Narayan, K. M., & Cowie, C. C. Mortality trends in men and women with diabetes, 1971 to 2000. Ann Iintern Med 147, 149-155 (2007
9. Secrest, A. M., Becker, D. J., Kelsey, S. F., LaPorte, R. E., & Orchard, T. J. All-cause mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes: The Allegheny County type 1 diabetes registry. Diabetes Care 33, 2573-2579 (2010
10. Secrest, A. M., Becker, D. J., Kelsey, S. F., Laporte, R. E., & Orchard, T. J. Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes. Diabetes 59, 3216-3222 (2010
11. Teupe, C., & Rosak, C. Diabetic cardiomyopathy and diastolic heart failure - difficulties with relaxation. Diabetes Res Clin Pract 97, 185-194 (2012
12. Slim, I. B. Cardiovascular risk in type 1 diabetes mellitus. Indian J Endocrinol Metab 17, S7-S13 (2013
13. Dobrin, J. S., & Lebeche, D. Diabetic cardiomyopathy: signaling defects and therapeutic approaches. Expert Rev Cardiovasc Ther 8, 373-391 (2010
14. Forbes, J. M., & Cooper, M. E. Mechanisms of diabetic complications. Physiol Rev 93, 137-188 (2013
15. Bers, D. M. Cardiac excitation-contraction coupling. Nature 415, 198-205 (2002
16. Bers, D. M. Calcium cycling and signaling in cardiac myocytes. Ann Rev Physiol 70, 23-49 (2008
17. Yaras, N., et al. Effects of diabetes on ryanodine receptor Ca release channel (RyR2) and Ca2+ homeostasis in rat heart. Diabetes 54, 3082-3088 (2005
18. Boudina, S., & Abel, E. D. Diabetic cardiomyopathy revisited. Circulation 115, 3213-3223 (2007
19. Carnicer, R., et al. Cardiomyocyte GTP cyclohydrolase 1 and tetrahydrobiopterin increase NOS1 activity and accelerate myocardial relaxation. Circ Res 111, 718-727 (2012
20. Xu, J., Wu, Y., Song, P., Zhang, M., Wang, S., & Zou, M. H. Proteasome-dependent degradation of guanosine 5' -Triphosphate cyclohydrolase I causes tetrahydrobiopterin deficiency in diabetes mellitus. Circulation 116, 944-953 (2007
21. Werner, E. R., Blau, N., & Thony, B. Tetrahydrobiopterin: biochemistry and pathophysiology. Biochem J 438, 397-414 (2011
22. Alkaitis, M. S., & Crabtree, M. J. Recoupling The cardiac nitric oxide synthases: tetrahydrobiopterin synthesis and recycling. Curr Heart Fail Rep 9, 200-210 (2012
23. Crabtree, M. J., et al. Quantitative regulation of intracellular endothelial nitric-oxide synthase (eNOS) coupling by both tetrahydrobiopterin-eNOS stoichiometry and biopterin redox status: insights from cells with tet-regulated GTP cyclohydrolase I expression. J Biol Chem 284, 1136-1144 (2009
24. Forstermann, U., & Munzel, T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 113, 1708-1714 (2006
25. Roe, N. D., He, E. Y., Wu, Z., & Ren, J. Folic acid reverses nitric oxide synthase uncoupling and prevents cardiac dysfunction in insulin resistance: role of Ca2+/calmodulin-Activated protein kinase II. Free Radic Biol Med 65, 234-243 (2013
26. Farah, C., et al. Exercise-induced cardioprotection: a role for eNOS uncoupling and NO metabolites. Basic Res Cardiol 108, 389 (2013
27. Khanna, S., Singh, G. B., & Khullar, M. Nitric oxide synthases and diabetic cardiomyopathy. Nitric oxide 43, 29-34 (2014
28. Zarubin, T., & Han, J. Activation and signaling of The p38 MAP kinase pathway. Cell Res 15, 11-18 (2005
29. Rajesh, M., et al. Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy. Diabetes 61, 716-727 (2012
30. Auger-Messier, M., et al. Unrestrained p38 MAPK activation in Dusp1/4 double-null mice induces cardiomyopathy. Circ Res 112, 48-56 (2013
31. Chiarini, A., Armato, U., Pacchiana, R., & Dal Pra, I. Proteomic analysis of GTP cyclohydrolase 1 multiprotein complexes in cultured normal adult human astrocytes under both basal and cytokine-Activated conditions. Proteomics 9, 1850-1860 (2009
32. Ge, Z. D., et al. Cardiac-specific overexpression of GTP cyclohydrolase 1 restores ischaemic preconditioning during hyperglycaemia. Cardiovasc Res 91, 340-349 (2011
33. Ionova, I. A., et al. Cardiac myocyte-specific overexpression of human GTP cyclohydrolase I protects against acute cardiac allograft rejection. American J Physiol Heart Circ Physiol 299, H88-96 (2010
34. Ceylan-Isik, A. F., et al. Metallothionein abrogates GTP cyclohydrolase I inhibition-induced cardiac contractile and morphological defects: role of mitochondrial biogenesis. Hypertension 53, 1023-1031 (2009
35. Liu, Y., et al. Inhibition of PKCβ 2 overexpression ameliorates myocardial ischaemia/reperfusion injury in diabetic rats via restoring caveolin-3/Akt signaling. Clin Sci 129, 331-344 (2015
36. Cingolani, O. H., Yang, X. P., Cavasin, M. A., & Carretero, O. A. Increased systolic performance with diastolic dysfunction in adult spontaneously hypertensive rats. Hypertension 41, 249-254 (2003
37. Drazner, M. H. The progression of hypertensive heart disease. Circulation 123, 327-334 (2011
38. Ge, Z. D., et al. Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5' -N-methylcarboxamide] reduces ischemia/reperfusion injury in mice by activating The A3 adenosine receptor. J Pharmacol Exp Ther 319, 1200-1210 (2006
39. Ge, Z. D., et al. Isoflurane postconditioning protects against reperfusion injury by preventing mitochondrial permeability transition by an endothelial nitric oxide synthase-dependent mechanism. Anesthesiology 112, 73-85 (2010
40. Like, A. A., & Rossini, A. A. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 193, 415-417 (1976
41. Wu, K. K., & Huan, Y. Streptozotocin-induced diabetic models in mice and rats. Curr Protoc Pharmacol 40, 5.47.1-5.47.14 (2008
42. Meloni, M., et al. Nerve growth factor gene therapy using adeno-Associated viral vectors prevents cardiomyopathy in type 1 diabetic mice. Diabetes 61, 229-240 (2012
43. Isfort, M., Stevens, S. C., Schaffer, S., Jong, C. J., & Wold, L. E. Metabolic dysfunction in diabetic cardiomyopathy. Heart Fail Rev 19, 35-48 (2014
44. Qiao, S., et al. MicroRNA-21 Mediates Isoflurane-induced Cardioprotection against Ischemia-Reperfusion Injury via Akt/Nitric Oxide Synthase/Mitochondrial Permeability Transition Pore Pathway. Anesthesiology 123, 786-798 (2015
45. Baumgardt, S. L., et al. Chronic Co-Administration of Sepiapterin and l-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic Mice. Circ Heart Fail 9, e002424 (2016
46. Pickert, G., et al. Inhibition of GTP cyclohydrolase reduces cancer pain in mice and enhances analgesic effects of morphine. J Mol Med 90, 1473-1486 (2012
47. Gustavsson, M., et al. Allosteric regulation of SERCA by phosphorylation-mediated conformational shift of phospholamban. Proc Natl Acad Sci USA 110, 17338-17343 (2013
48. Simmerman, H. K., & Jones, L. R. Phospholamban: protein structure, mechanism of action, and role in cardiac function. Physiol Rev 78, 921-947 (1998
49. Seddon, M., Shah, A. M., & Casadei, B. Cardiomyocytes as effectors of nitric oxide signalling. Cardiovasc Res 75, 315-326 (2007
50. Toda, N. Age-related changes in endothelial function and blood flow regulation. Pharmacol Ther 133, 159-176 (2012
51. Barouch, L. A., et al. Nitric oxide regulates The heart by spatial confinement of nitric oxide synthase isoforms. Nature 416, 337-339 (2002
52. Voigt, N., et al. Cellular and molecular mechanisms of atrial arrhythmogenesis in patients with paroxysmal atrial fibrillation. Circulation 129, 145-156 (2014
53. Hirano, E., Shimada, K., Komiyama, T., Fujita, M., & Kishimoto, C. Erythromycin treatment suppresses myocardial injury in autoimmune myocarditis in rats via suppression of superoxide production. Intern J Cardiol 167, 2228-2233 (2013
54. Baotic, I., et al. Isoflurane favorably modulates guanosine triphosphate cyclohydrolase-1 and endothelial nitric oxide synthase during myocardial ischemia and reperfusion injury in rats. Anesthesiology 123, 582-589 (2015
55. Feng, Q., Lu, X., Jones, D. L., Shen, J., & Arnold, J. M. Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice. Circulation 104, 700-704 (2001
56. Marfella, R., et al. Absence of inducible nitric oxide synthase reduces myocardial damage during ischemia reperfusion in streptozotocin-induced hyperglycemic mice. Diabetes 53, 454-462 (2004
57. Stuehr, D., Pou, S., & Rosen, G. M. Oxygen reduction by nitric-oxide synthases. J Biol Chem 276, 14533-14536 (2001
58. Bendall, J. K., Douglas, G., McNeill, E., Channon, K. M., & Crabtree, M. J. Tetrahydrobiopterin in cardiovascular health and disease. Antioxid Redox Signal 20, 3040-3077 (2014
59. Liao, P., et al. The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy. Proc Natl Acad Sci USA 98, 12283-12288 (2001
60. Andrews, C., Ho, P. D., Dillmann, W. H., Glembotski, C. C., & McDonough, P. M. The MKK6-p38 MAPK pathway prolongs The cardiac contractile calcium transient, downregulates SERCA2, and activates NF-AT. Cardiovasc Res 59, 46-56 (2003
61. Scharf, M., et al. Mitogen-Activated protein kinase-Activated protein kinases 2 and 3 regulate SERCA2a expression and fiber type composition to modulate skeletal muscle and cardiomyocyte function. Mol Cell Biol 33, 2586-2602 (2013
62. Kaikkonen, L., et al. p38alpha regulates SERCA2a function. J Mol Cell Cardiol 67, 86-93 (2014
63. Wang, Y., et al. Therapeutic effect of MG-132 on diabetic cardiomyopathy is associated with its suppression of proteasomal activities: roles of Nrf2 and NF-kappaB. Am J Physiol Heart Circ Physiol 304, H567-578 (2013
64. Gomes, A. V., Zong, C., & Ping, P. Protein degradation by The 26S proteasome system in The normal and stressed myocardium. Antioxid Redox Signal 8, 1677-1691 (2006
65. Lecker, S. H., Goldberg, A. L., & Mitch, W. E. Protein degradation by The ubiquitin-proteasome pathway in normal and disease states. J Am Soc Nephrol 17, 1807-1819 (2006
66. Inobe, T., & Genmei, R. Inhibition of The 26S proteasome by peptide mimics of The coiled-coil region of its ATPase subunits. Biochem Biophys Res Commun 468, 143-150 (2015
67. Al Kury, L. T., et al. Effects of endogenous cannabinoid anandamide on excitation-contraction coupling in rat ventricular myocytes. Cell Calcium 55, 104-118 (2014
68. An, J., Du, J., Wei, N., Xu, H., Pritchard, K. A. Jr., & Shi, Y. Role of tetrahydrobiopterin in resistance to myocardial ischemia in Brown Norway and Dahl S rats. Am J Physiol Heart Circ Physiol 297, H1783-1791 (2009
69. Vladic, N., et al. Decreased tetrahydrobiopterin and disrupted association of Hsp90 with eNOS by hyperglycemia impair myocardial ischemic preconditioning. Am J Physiol Heart Circ Physiol 301, H2130-2139 (2011
70. Leucker, T. M., et al. Impairment of endothelial-myocardial interaction increases The susceptibility of cardiomyocytes to ischemia/reperfusion injury. PloS One 8, e70088 (2013
71. Han, Y., et al. l-Tetrahydropalmatine, an active component of Corydalis yanhusuo W.T. Wang, protects against myocardial ischaemiareperfusion injury in rats. PloS One 7, e38627 (2012
72. Shang, T., Kotamraju, S., Kalivendi, S. V., Hillard, C. J., & Kalyanaraman, B. 1-Methyl-4-phenylpyridinium-induced apoptosis in cerebellar granule neurons is mediated by transferrin receptor iron-dependent depletion of tetrahydrobiopterin and neuronal nitricoxide synthase-derived superoxide. J Biol Chem 279, 19099-19112 (2004